Effectiveness of Scotland 's National Naloxone Programme for reducing opioid‐related deaths: a before (2006–10) versus after (2011–13) comparison
Open accessAbstract
Aims: To assess the effectiveness for Scotland 's National Naloxone Programme (NNP) by comparison between 2006–10 (before) and 2011–13 (after NNP started in January 2011) and to assess cost‐effectiveness. Design: This was a pre–post evaluation of a national policy. Cost‐effectiveness was assessed by prescription costs against life‐years gained per opioid‐related death (ORD) averted. Setting: Scotland , in community settings and all prisons. Intervention: Brief training and standardized naloxone supply became available to individuals at risk of opioid overdose. Measurements: ORDs as identified by National Records of Scotland . Look‐back determined the proportion of ORDs who, in the 4 weeks before ORD, had been (i) released from prison (primary outcome) and (ii) released from prison or discharged from hospital (secondary). We report 95% confidence intervals for effectiveness in reducing the primary (and secondary) outcome in 2011–13 versus 2006–10. Prescription costs were assessed against 1 or 10 life‐years gained per averted ORD. Findings: In 2006–10, 9.8% of ORDs (193 of 1970) were in people released from prison within 4 weeks of death, whereas only 6.3% of ORDs in 2011–13 followed prison release (76 of 1212, P < 0.001; this represented a difference of 3.5% [95% confidence interval (CI) = 1.6–5.4%)]. This reduction in the proportion of prison release ORDs translates into 42 fewer prison release ORDs (95% CI = 19–65) during 2011–13, when 12 000 naloxone kits were issued at current prescription cost of £225 000. Scotland 's secondary outcome reduced from 19.0 to 14.9%, a difference of 4.1% (95% CI = 1.4–6.7%). Conclusions: Scotland 's National Naloxone Programme, which started in 2011, was associated with a 36% reduction in the proportion of opioid‐related deaths that occurred in the 4 weeks following release from prison.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Bird et al. showed, again with methods from data science, the effectiveness of their intervention: the number of deaths decreased significantly.
“They showed, again with methods from data science, the effectiveness of their intervention: the number of deaths decreased significantly.”
From AI for the Common Good?! Pitfalls, challenges, and ethics pen-testing (2019) · cites this paper as [31]
The Findings (page unavailable) report a statistically significant reduction in the proportion of opioid-related deaths occurring within four weeks of prison release and estimate 42 fewer such deaths in 2011–13. The Conclusion (page unavailable) says this reduction may be due to the naloxone programme. The claim overstates the result by implying a significant decrease in deaths overall and attributing that decrease definitively to the intervention. (LLM, conf=0.88)
Experimental — accuracy not yet measuredBird et al. used a data-science analysis to show the prevalence of lethal overdoses among addicts recently released from prison, and then handed out emergency overdose kits and gave basic information on how to administer the antidote.
“The authors used a data-science analysis to show the prevalence of lethal overdoses among addicts recently released from prison (at which time addicts are even more vulnerable than usual due to the enforced abstinence while in prison), and then instead of arguing for an awareness campaign 'to avoid drugs' or 'avoid overdosing', handed out emergency overdose kits and gave basic information on how”
From AI for the Common Good?! Pitfalls, challenges, and ethics pen-testing (2019) · cites this paper as [31]
The Results (page not provided) report the proportion of opioid-related deaths occurring within four weeks of prison release, and the Introduction describes brief training and naloxone-on-release in Scotland. But that proportion is not the prevalence of lethal overdose among people released from prison. The authors evaluated Scotland’s programme; the paper does not say they personally distributed the kits or delivered the training. (LLM, conf=0.87)
Experimental — accuracy not yet measuredScotland's National Naloxone Programme was followed by a 36% reduction in the proportion of opioid-related deaths in prisoners during the 4 weeks following their release from prison.
“A before (2006-10) -after (2011-13) comparison of Scotland’s National Naloxone Programme found a 36% reduction in the proportion of opioid-related deaths in prisoners during the 4 weeks following their release from prison after the program was initiated [39].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,302 · see citing works
The Environment and Disease: Association or Causation?
Hill, A. B. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800503 · Cited by 6,974 · see citing works
Meta‐analysis of drug‐related deaths soon after release from prison
Merrall, E. L. C., Kariminia, A., Binswanger, I. A., HOBBS, M. S. T., Farrell, M., Marsden, J., Hutchinson, S. J., & Bird, S. M. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.02990.x · Cited by 689 · see citing works
Self-citationBrazier, R. (1998) · Research Explorer (The University of Manchester) · Cited by 442 · see citing works
Cost-Effectiveness of Distributing Naloxone to Heroin Users for Lay Overdose Reversal
Coffin, P. O., & Sullivan, S. D. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-1-201301010-00003 · Cited by 347 · see citing works
Seaman, S. R., Brettle, R. P., & Gore, S. M. (1998) · BMJ · doi:10.1136/bmj.316.7129.426 · Cited by 292 · see citing works
Community-Based Opioid Overdose Prevention Programs Providing Naloxone —United States, 2010
Wheeler, E., Davidson, P. J., Jones, T. S., & Irwin, K. S. (2012) · JAMA · doi:10.1001/jama.307.13.1358 · Cited by 257 · see citing works
Seal, K. H. (2005) · Journal of Urban Health · doi:10.1093/jurban/jti053 · Cited by 244 · see citing works
Male drugs‐related deaths in the fortnight after release from prison: Scotland, 1996–99
Bird, S. M., & Hutchinson, S. J. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00264.x · Cited by 239 · see citing works
Self-citationDegenhardt, L. J., Larney, S., Kimber, J., Gisev, N., Farrell, M., Dobbins, T., Weatherburn, D., Gibson, A., Mattick, R. P., Butler, T. G., et al. (2014) · Addiction · doi:10.1111/add.12536 · Cited by 223 · see citing works
Project Lazarus: community-based overdose prevention in rural North Carolina
Albert, S., Brason, F. W., Sanford, C. K., Dasgupta, N., Graham, J., & Lovette, B. (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01128.x · Cited by 210 · see citing works
Wagner, K. D., Valente, T. W., Casanova, M., Partovi, S. M., Mendenhall, B. M., Hundley, J. H., Gonzalez, M., & Unger, J. B. (2009) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2009.01.003 · Cited by 192 · see citing works
Overdose Prevention and Naloxone Prescription for Opioid Users in San Francisco
Enteen, L., Bauer, J., McLean, R., Wheeler, E., Huriaux, E., Kral, A. H., & Bamberger, J. D. (2010) · Journal of Urban Health · doi:10.1007/s11524-010-9495-8 · Cited by 185 · see citing works
Heroin overdose: the case for take-home naloxone
Strang, J., Darke, S. G., Hall, W., Farrell, M., & Ali, R. L. (1996) · BMJ · doi:10.1136/bmj.312.7044.1435 · Cited by 173 · see citing works
Tobin, K. E., Sherman, S. G., Beilenson, P. L., Welsh, C., & Latkin, C. A. (2008) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2008.03.002 · Cited by 149 · see citing works
Galea, S., Worthington, N., Piper, T. M., Nandi, V., Curtis, M., & ROSENTHAL, D. M. (2005) · Addictive Behaviors · doi:10.1016/j.addbeh.2005.07.020 · Cited by 131 · see citing works
Strang, J., Bird, S. M., & Parmar, M. (2013) · Journal of Urban Health · doi:10.1007/s11524-013-9803-1 · Cited by 79 · see citing works
Self-citationBird, S. M., Parmar, M., & Strang, J. (2014) · Drugs Education Prevention and Policy · doi:10.3109/09687637.2014.981509 · Cited by 76 · see citing works
Self-citationMerrall, E. L. C., Bird, S. M., & Hutchinson, S. J. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.04066.x · Cited by 73 · see citing works
Self-citationBird, S. M., Fischbacher, C., Graham, L., & Fraser, A. (2015) · Addiction · doi:10.1111/add.12969 · Cited by 65 · see citing works
Self-citationFrom evidence to policy: The Scottish national naloxone programme
McAuley, A., Best, D. W., Taylor, A., Hunter, C., & Robertson, R. (2012) · Drugs Education Prevention and Policy · doi:10.3109/09687637.2012.682232 · Cited by 65 · see citing works
Self-citationLow incidence of hepatitis C virus among prisoners in S cotland
Taylor, A., Munro, A., Allen, E., Dunleavy, K., Cameron, S., Miller, L. L., & Hickman, M. (2013) · Addiction · doi:10.1111/add.12107 · Cited by 54 · see citing works
Emergency naloxone for heroin overdose
Strang, J., Kelleher, M., Best, D. W., Mayet, S., & Manning, V. (2006) · BMJ · doi:10.1136/bmj.333.7569.614 · Cited by 51 · see citing works
McDonald, S., Hutchinson, S. J., Palmateer, N. E., Allen, E., Cameron, S., Goldberg, D. J., & Taylor, A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.004 · Cited by 48 · see citing works
White, S. R., Bird, S. M., Merrall, E. L. C., & Hutchinson, S. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141073 · Cited by 39 · see citing works
Self-citationTake-home emergency naloxone to prevent deaths from heroin overdose
Strang, J., Bird, S. M., Dietze, P., Gerra, G., & McLellan, A. T. (2014) · BMJ · doi:10.1136/bmj.g6580 · Cited by 36 · see citing works
Self-citationEditorial: Counting the Dead Properly and Promptly
Bird, S. M. (2013) · Journal of the Royal Statistical Society Series A (Statistics in Society) · doi:10.1111/rssa.12035 · Cited by 17 · see citing works
Self-citationCounting the dead: properly and promptly
Bird, S. M. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61077-6 · Cited by 12 · see citing works
Self-citationWhite, S. R., Bird, S. M., & Grieve, R. (2013) · Journal of the Royal Statistical Society Series A (Statistics in Society) · doi:10.1111/rssa.12030 · Cited by 3 · see citing works
Self-citationSanai, L. (2006) · BMJ · doi:10.1136/bmj.332.7533.sgp20 · Cited by 2 · see citing works
Flagged first, then by citations
1 of the 31 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- [10]Bird S. M., Fischbacher C. M., Graham L., Fraser A. Impact of Scottish prisons' opioid substitution therapy on drugs‐related deaths soon after prisoner‐release. Addiction 2015; 110: 1617– 24. 25940815 PMC4744745
- [26]Rapid responses to British Medical Journal article (editorial). Available at: http://www.bmj.com/content/333/7569/614 (Archived at http://www.webcitation.org/6amOTQaGB on 14 August 2015) (accessed 14 August 2015).
Cited by
Sorted by citations
Humphreys, K. N., Shover, C. L., Andrews, C. M., Bohnert, A. S. B., Brandeau, M. L., Caulkins, J. P., Chen, J. H., Cuéllar, M.-F., Hurd, Y. L., Juurlink, D. N., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02252-2 · Cited by 463 · see citing works
Fairbairn, N. S., Coffin, P. O., & Walley, A. Y. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.06.005 · Cited by 275 · see citing works
Irvine, M. A., Kuo, M. E., Buxton, J. A., Balshaw, R. F., Otterstatter, M. C., MacDougall, L., Milloy, M., Bharmal, A., Henry, B., TYNDALL, M. W., et al. (2019) · Addiction · doi:10.1111/add.14664 · Cited by 233 · see citing works
Marsden, J., Stillwell, G., Jones, H. E., Cooper, A., Eastwood, B., Farrell, M., Lowden, T., Maddalena, N., Metcalfe, C. D., Shaw, J. J., et al. (2017) · Addiction · doi:10.1111/add.13779 · Cited by 187 · see citing works
Malta, M., Varatharajan, T., Russell, C., Pang, M., Bonato, S., & Fischer, B. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1003002 · Cited by 171 · see citing works
Opioid overdose prevention and naloxone rescue kits: what we know and what we don’t know
Kerensky, T., & Walley, A. Y. (2017) · Addiction Science & Clinical Practice · doi:10.1186/s13722-016-0068-3 · Cited by 158 · see citing works
Bukten, A., Stavseth, M. R., Skurtveit, S. O., Tverdal, A., Strang, J., & Clausen, T. (2017) · Addiction · doi:10.1111/add.13803 · Cited by 155 · see citing works
McDonald, R., CAMPBELL, N. D., & Strang, J. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.05.001 · Cited by 147 · see citing works
Green, T. C., Case, P., Fiske, H., Baird, J. B., Cabral, S., Burstein, D., Schwartz, V., Potter, N., Walley, A. Y., & Bratberg, J. P. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2017.01.013 · Cited by 139 · see citing works
Winhusen, T. M., Walley, A. Y., Fanucchi, L. C., Hunt, T., Lyons, M., Lofwall, M. R., Brown, J. L., Freeman, P. R., Nunes, E. V., Beers, D., et al. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108325 · Cited by 133 · see citing works
Mital, S., Wolff, J., & Carroll, J. J. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108088 · Cited by 122 · see citing works
Duber, H. C., Barata, I. A., Cioè‐Peña, E., Liang, S. Y., Ketcham, E. M., Macias‐Konstantopoulos, W., Ryan, S. A., Stavros, M., & Whiteside, L. (2018) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2018.04.007 · Cited by 116 · see citing works
Pizzicato, L. N., Drake, R., Domer-Shank, R. B., Johnson, C. C., & Viner, K. M. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.04.034 · Cited by 114 · see citing works
Irvine, M. A., Buxton, J. A., Otterstatter, M. C., Balshaw, R. F., Gustafson, R., TYNDALL, M. W., Kendall, P., Kerr, T. H., Gilbert, M., & Coombs, D. (2018) · The Lancet Public Health · doi:10.1016/s2468-2667(18)30044-6 · Cited by 104 · see citing works
Stone, J., Martin, N. K., Hickman, M., Hutchinson, S. J., Aspinall, E., Taylor, A., Munro, A., Dunleavy, K., Peters, E., Bramley, P. N., et al. (2017) · Addiction · doi:10.1111/add.13783 · Cited by 96 · see citing works
Chimbar, L., & Moleta, Y. (2018) · Journal of Addictions Nursing · doi:10.1097/jan.0000000000000230 · Cited by 92 · see citing works
Meyerson, B. E., Agley, J. D., Davis, A., Jayawardene, W. P., Hoss, A., Shannon, D. J., Ryder, P. T., Ritchie, K., & Gassman, R. A. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.03.032 · Cited by 89 · see citing works
Balancing opioid analgesia with the risk of nonmedical opioid use in patients with cancer
Arthur, J. A., & Bruera, E. D. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0143-7 · Cited by 90 · see citing works
The impact of the opioid crisis on U.S. state prison systems
Scott, C. K., Dennis, M. L., Grella, C. E., Mischel, A. F., & Carnevale, J. T. (2021) · Health & Justice · doi:10.1186/s40352-021-00143-9 · Cited by 84 · see citing works
Baldwin, N., Gray, R., Goel, A., Wood, E., Buxton, J. A., & Rieb, L. M. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.12.032 · Cited by 83 · see citing works
Townsend, T., Blostein, F., Doan, T., Madson-Olson, S., Galecki, P., & Hutton, D. W. (2020) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.07.031 · Cited by 83 · see citing works
Graves, R., Andreyeva, E., Perrone, J., Shofer, F., Merchant, R., & Meisel, Z. F. (2019) · Journal of addiction medicine · doi:10.1097/adm.0000000000000492 · Cited by 65 · see citing works
Parmar, M., Strang, J., Choo, L., Meade, A. M., & Bird, S. M. (2016) · Addiction · doi:10.1111/add.13668 · Cited by 79 · see citing works
Self-citationProjected estimates of opioid mortality after community-level interventions.
Linas, B. P., Savinkina, A., Madushani, R. W. M. A., Wang, J., Eftekhari Yazdi, G., Chatterjee, A., Walley, A. Y., Morgan, J. R., Epstein, R. L., Assoumou, S. A., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.37259 · Cited by 72 · see citing works
The Global State of Harm Reduction in Prisons
Sander, G., Shirley‐Beavan, S., & Stone, K. (2019) · Journal of Correctional Health Care · doi:10.1177/1078345819837909 · Cited by 74 · see citing works
Hjemsæter, A. J., Bramness, J. G., Drake, R. E., Skeie, I., Monsbakken, B., Benth, J. Š., & Landheim, A. S. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2077-8 · Cited by 71 · see citing works
Hartung, D. M., McCracken, C. M., Nguyen, T. D., Kempany, K. G., & Waddell, E. N. (2023) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2023.208971 · Cited by 75 · see citing works
Langham, S., Wright, A., Kenworthy, J., Grieve, R., & Dunlop, W. (2018) · Value in Health · doi:10.1016/j.jval.2017.07.014 · Cited by 70 · see citing works
Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review
Behar, E., Bagnulo, R., & Coffin, P. O. (2018) · Preventive Medicine · doi:10.1016/j.ypmed.2018.06.005 · Cited by 67 · see citing works
Fischer, L. S., Asher, A., Stein, R., Becasen, J., Doreson, A., Mermin, J., Meltzer, M. I., & Edlin, B. R. (2025) · BMC Public Health · doi:10.1186/s12889-025-22210-8 · Cited by 59 · see citing works
“A before (2006-10) -after (2011-13) comparison of Scotland’s National Naloxone Programme found a 36% reduction in the proportion of opioid-related deaths in prisoners during the 4 weeks following their release from prison after the program was initiated [39].”
Rapid widespread distribution of intranasal naloxone for overdose prevention
Eide, D., Clausen, T., & Lobmaier, P. P. K. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.12.013 · Cited by 56 · see citing works
Neale, J., Brown, C., Campbell, A. N. C., Jones, J. D., Metz, V. E., Strang, J., & Comer, S. D. (2018) · Addiction · doi:10.1111/add.14510 · Cited by 55 · see citing works
Lewis, C., Vo, H. T., & Fishman, M. J. (2017) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s101700 · Cited by 54 · see citing works
Collins, A. B., Ndoye, C. D., Arene-Morley, D., & Marshall, B. D. L. (2020) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2020.102872 · Cited by 52 · see citing works
Watson, D. P., Ray, B. R., Robison, L., Huynh, P., Sightes, E., Walker, L. S., Brucker, K., & Duwve, J. M. (2018) · Harm Reduction Journal · doi:10.1186/s12954-018-0226-x · Cited by 51 · see citing works
Ebbert, J. O., Philpot, L. M., Clements, C. M., Lovely, J. K., Nicholson, W. T., Jenkins, S. M., Lamer, T. J., & Gazelka, H. M. (2017) · Pain Medicine · doi:10.1093/pm/pnx140 · Cited by 50 · see citing works
Karamouzian, M., Kuo, M. E., Crabtree, A., & Buxton, J. A. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.01.006 · Cited by 50 · see citing works
Periods of altered risk for non-fatal drug overdose: a self-controlled case series
Keen, C., Kinner, S. A., Young, J. T., Snow, K. J., Zhao, B., Gan, W., & Slaunwhite, A. (2021) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00007-4 · Cited by 51 · see citing works
Macmadu, A., Goedel, W. C., Adams, J. W., Brinkley‐Rubinstein, L., Green, T. C., Clarke, J. G., Martin, R. A., Rich, J. D., & Marshall, B. D. L. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.107858 · Cited by 48 · see citing works
An overview of take‐home naloxone programs in Australia
Dwyer, R., Olsen, A., Fowlie, C., Gough, C. M., van Beek, I., JAUNCEY, M. E., Lintzeris, N., Oh, G., Dicka, J., FRY, C. L., et al. (2018) · Drug and Alcohol Review · doi:10.1111/dar.12812 · Cited by 48 · see citing works
Overdose Education and Naloxone Distribution in the San Francisco County Jail
Wenger, L. D., Showalter, D., Lambdin, B. H., Leiva, D., Wheeler, E., Davidson, P. J., Coffin, P. O., Binswanger, I. A., & Kral, A. H. (2019) · Journal of Correctional Health Care · doi:10.1177/1078345819882771 · Cited by 48 · see citing works
Uyei, J., Fiellin, D. A., Buchelli, M., Rodriguez-Santana, R., & Braithwaite, R. S. (2017) · The Lancet Public Health · doi:10.1016/s2468-2667(17)30006-3 · Cited by 55 · see citing works
Coffin, P. O., Santos, G.-M., Matheson, T., Behar, E., Rowe, C., Rubin, T., Silvis, J., & Vittinghoff, E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183354 · Cited by 44 · see citing works
A mapping review of take-home naloxone for people released from correctional settings
Horton, M., McDonald, R., Green, T. C., Nielsen, S., Strang, J., Degenhardt, L. J., & Larney, S. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.05.015 · Cited by 44 · see citing works
Primary Care Patient Experience with Naloxone Prescription
Behar, E., Rowe, C. L., Santos, G., Murphy, S., & Coffin, P. O. (2016) · The Annals of Family Medicine · doi:10.1370/afm.1972 · Cited by 43 · see citing works
Binswanger, I. A., Nguyen, A. P., Morenoff, J. D., Xu, S., & Harding, D. J. (2020) · Addiction · doi:10.1111/add.15077 · Cited by 43 · see citing works
Considering the Potential Benefits of Over-the-Counter Naloxone
Evoy, K. E., Hill, L. G., & Davis, C. S. (2021) · Integrated Pharmacy Research and Practice · doi:10.2147/iprp.s244709 · Cited by 43 · see citing works
Grella, C. E., Ostlie, E. M., Scott, C. K., Dennis, M. L., Carnevale, J. T., & Watson, D. P. (2021) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-021-00346-1 · Cited by 43 · see citing works
Chhatwal, J., Mueller, P. P., Chen, Q., Kulkarni, N. S., Adee, M. G., Zarkin, G. A., Larochelle, M. R., Knudsen, A. B., & Barbosa, C. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.14925 · Cited by 42 · see citing works
Gao, L., Dimitropoulou, P., Robertson, R., McTaggart, S., Bennie, M., & Bird, S. M. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.08.627 · Cited by 42 · see citing works
Self-citationCurrent State of Opioid Therapy and Abuse
Manchikanti, L., Kaye, A. M., & Kaye, A. D. (2016) · Current Pain and Headache Reports · doi:10.1007/s11916-016-0564-x · Cited by 41 · see citing works
Engagement in a National Naloxone Programme among people who inject drugs
McAuley, A., Munro, A., Bird, S. M., Hutchinson, S. J., Goldberg, D. J., & Taylor, A. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.02.031 · Cited by 41 · see citing works
Self-citationvan Amsterdam, J., van den Brink, W., & Pierce, M. (2021) · European Addiction Research · doi:10.1159/000516165 · Cited by 40 · see citing works
McAuley, A., Munro, A., & Taylor, A. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.05.002 · Cited by 39 · see citing works
Self-citationParry, R. A., Zule, W. A., Hurt, C. B., Evon, D. M., Rhea, S. K., & Carpenter, D. M. (2021) · Harm Reduction Journal · doi:10.1186/s12954-021-00517-0 · Cited by 39 · see citing works
Gao, L., Robertson, R., & Bird, S. M. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.01.019 · Cited by 38 · see citing works
Self-citationNaloxone distribution and possession following a large‐scale naloxone programme
Eide, D., Gjersing, L., & Clausen, T. (2018) · Addiction · doi:10.1111/add.14425 · Cited by 37 · see citing works
Berland, N., Lugassy, D. M., Fox, A. D., Goldfeld, K. S., Oh, S.-Y., Tofighi, B., & Hanley, K. (2019) · Substance Abuse · doi:10.1080/08897077.2019.1572048 · Cited by 37 · see citing works
Scotland's National Naloxone Programme
Bird, S. M., & McAuley, A. (2019) · The Lancet · doi:10.1016/s0140-6736(18)33065-4 · Cited by 36 · see citing works
Self-citationZang, X., Macmadu, A., Krieger, M. S., Behrends, C. N., Green, T. C., Morgan, J. R., Murphy, S. M., Nolen, S., Walley, A. Y., Schackman, B. R., et al. (2021) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103435 · Cited by 36 · see citing works
Stöver, H., Tarján, A., Horvath, G., Montanari, L., & Hedrich, D. (2021) · Harm Reduction Journal · doi:10.1186/s12954-021-00506-3 · Cited by 35 · see citing works
Emergency care with lay responders in underserved populations: a systematic review
Orkin, A. M., Venugopal, J., Curran, J. D., Fortune, M., McArthur, A., Mew, E. J., Ritchie, S. D., Drennan, I. R., Exley, A., Jamieson, R., et al. (2021) · Bulletin of the World Health Organization · doi:10.2471/blt.20.270249 · Cited by 38 · see citing works
Naloxone use among overdose prevention trainees in New York City: A longitudinal cohort study
Siegler, A., Huxley‐Reicher, Z., Maldjian, L., Jordan, R., Oliver, C., Jakubowski, A. U., & Kunins, H. V. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.06.029 · Cited by 34 · see citing works
Retention of Student Pharmacists’ Knowledge and Skills regarding Overdose Management with Naloxone
Jacobson, A. N., Bratberg, J. P., Monk, M., & Ferrentino, J. (2018) · Substance Abuse · doi:10.1080/08897077.2018.1439797 · Cited by 33 · see citing works
Opioids and the Criminal Justice System: New Challenges Posed by the Modern Opioid Epidemic
Caulkins, J. P., Gould, A., Pardo, B., Reuter, P., & Stein, B. D. (2020) · Annual Review of Criminology · doi:10.1146/annurev-criminol-061020-125715 · Cited by 33 · see citing works
Green, T. C., Bratberg, J. P., Baird, J. B., Burstein, D., Lenz, K., Case, P., Walley, A. Y., & Xuan, Z. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.11.010 · Cited by 32 · see citing works
Chatterjee, A., Yan, S., Xuan, Z., Waye, K. M., Lambert, A. M., Green, T. C., Stopka, T. J., Pollini, R. A., Morgan, J. R., & Walley, A. Y. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.109190 · Cited by 32 · see citing works
McAuley, A., Bouttell, J., Barnsdale, L. R., Mackay, D., Lewsey, J., Hunter, C., & Robinson, M. (2016) · Addiction · doi:10.1111/add.13602 · Cited by 32 · see citing works
Self-citationAssembling the Social and Political Dimensions of Take-Home Naloxone
Farrugia, A., Fraser, S., & Dwyer, R. (2017) · Contemporary Drug Problems · doi:10.1177/0091450917723350 · Cited by 31 · see citing works
Ageing opioid users’ increased risk of methadone-specific death in the UK
Pierce, M., Millar, T., Robertson, J. R., & Bird, S. M. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.02.005 · Cited by 31 · see citing works
Self-citationDwyer, R., Fraser, S., & Dietze, P. (2016) · Drugs Education Prevention and Policy · doi:10.3109/09687637.2016.1150964 · Cited by 30 · see citing works
O’Halloran, C., Cullen, K. J., Njoroge, J., Jessop, L., Smith, J., Hope, V. D., & Ncube, F. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.05.017 · Cited by 29 · see citing works
Hedrich, D., & Hartnoll, R. (2020) · Springer eBooks · doi:10.1007/978-3-030-36391-8_52 · Cited by 28 · see citing works
Curtis, M., Dietze, P., Aitken, C. K., Kirwan, A., Kinner, S. A., Butler, T. G., & Stoove, M. A. (2018) · Harm Reduction Journal · doi:10.1186/s12954-018-0255-5 · Cited by 28 · see citing works
Circumstances of overdose among street-involved, opioid-injecting women: Drug, set, and setting
Ataiants, J., Roth, A. M., Mazzella, S., & Lankenau, S. E. (2020) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2020.102691 · Cited by 28 · see citing works
Cooper, J. A., Onyeka, I. N., Cardwell, C. R., Paterson, E., Kirk, R., O’Reilly, D., & Donnelly, M. (2023) · BMC Public Health · doi:10.1186/s12889-023-15673-0 · Cited by 27 · see citing works
Lambdin, B. H., Wenger, L. D., Bluthenthal, R. N., Bartholomew, T. S., Tookes, H. E., LaKosky, P. A., O’Neill, S., & Kral, A. H. (2023) · Harm Reduction Journal · doi:10.1186/s12954-023-00755-4 · Cited by 25 · see citing works
Gicquelais, R. E., Mezuk, B. R., Foxman, B., Thomas, L., & Bohnert, A. S. B. (2019) · Harm Reduction Journal · doi:10.1186/s12954-019-0317-3 · Cited by 26 · see citing works
Community Distribution of Naloxone: A Systematic Review of Economic Evaluations
Cherrier, N., Kearon, J., Tetreault, R., Garasia, S., & Guindon, G. E. (2021) · PharmacoEconomics - Open · doi:10.1007/s41669-021-00309-z · Cited by 26 · see citing works
The Effect of Naloxone Access Laws on Fatal Synthetic Opioid Overdose Fatality Rates
Tabatabai, M., Cooper, R. L., Wilus, D. M., Edgerton, R. D., Ramesh, A., MacMaster, S. A., Patel, P. N., & Singh, K. P. (2023) · Journal of Primary Care & Community Health · doi:10.1177/21501319221147246 · Cited by 26 · see citing works
Expanding Access to Naloxone: A Review of Distribution Strategies
Weiner, J., Murphy, S. M., & Behrends, C. N. (2019) · ScholarlyCommons (University of Pennsylvania) · Cited by 26 · see citing works
Pizzicato, L. N., Johnson, C. C., & Viner, K. M. (2019) · Substance Abuse · doi:10.1080/08897077.2019.1675115 · Cited by 26 · see citing works
Macdonald, C., Macpherson, G., Leppan, O., Tran, L. T., Cunningham, E. B., Hajarizadeh, B., Grebely, J., Farrell, M., Altice, F. L., & Degenhardt, L. J. (2024) · The Lancet Public Health · doi:10.1016/s2468-2667(24)00160-9 · Cited by 31 · see citing works
O’Brien, D. C., Dabbs, D., Dong, K. A., Veugelers, P. J., & Hyshka, E. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4469-3 · Cited by 26 · see citing works
Prison-based prescriptions aid Scotland's National Naloxone Programme
Bird, S. M., McAuley, A., Munro, A., Hutchinson, S. J., & Taylor, A. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30656-6 · Cited by 24 · see citing works
Self-citationScotland's national naloxone program: The prison experience
Horsburgh, K., & McAuley, A. (2017) · Drug and Alcohol Review · doi:10.1111/dar.12542 · Cited by 22 · see citing works
Self-citationKobayashi, L., Green, T. C., Bowman, S. E., Ray, M., McKenzie, M., & Rich, J. D. (2016) · Simulation in Healthcare The Journal of the Society for Simulation in Healthcare · doi:10.1097/sih.0000000000000182 · Cited by 22 · see citing works
Stakeholders’ Perceptions of Factors Influencing the Use of Take-Home-Naloxone
Holland, T. J., Penm, J. H.-D., Johnson, J. L., Sarantou, M., & Chaar, B. B. (2020) · Pharmacy · doi:10.3390/pharmacy8040232 · Cited by 21 · see citing works
Is systematic training in opioid overdose prevention effective?
Espelt, A., Bosque‐Prous, M., Folch, C., Sarasa‐Renedo, A., Majó, X., Casabona, J., Brugal, M. T., & REDAN Group (2017) · PLoS ONE · doi:10.1371/journal.pone.0186833 · Cited by 21 · see citing works
Assessing pharmacy-based naloxone access using an innovative purchase trial methodology
Pollini, R. A., Joyce, R., Ozga‐Hess, J. E., Xuan, Z., Green, T. C., & Walley, A. Y. (2020) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2020.05.016 · Cited by 21 · see citing works
Kalk, N. J., Robertson, R., Kidd, B., Day, E., Kelleher, M., Gilvarry, E. A., & Strang, J. (2017) · European Journal on Criminal Policy and Research · doi:10.1007/s10610-017-9364-z · Cited by 20 · see citing works
Santa, H., Amirova, S. G., Ventricelli, D. J., Downs, G. E., Nowalk, A., Pringle, J. L., & Aruru, M. (2020) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxaa387 · Cited by 21 · see citing works
Nolan, S., Buxton, J. A., Dobrer, S., Dong, H., Hayashi, K., Milloy, M., Kerr, T. H., Montaner, J. S. G., & Wood, E. (2017) · Public Health Reports · doi:10.1177/0033354917717230 · Cited by 20 · see citing works
Endogenous opiates and behavior: 2017
Bodnar, R. J. (2019) · Peptides · doi:10.1016/j.peptides.2019.170223 · Cited by 19 · see citing works
Ramdin, C., Guo, M., Fabricant, S., Santos, C. D., & Nelson, L. S. (2021) · Substance Use & Misuse · doi:10.1080/10826084.2021.2023187 · Cited by 19 · see citing works
Byrne, C. J., Sani, F., Thain, D., Fletcher, E. H., & Malaguti, A. (2024) · Harm Reduction Journal · doi:10.1186/s12954-024-00999-8 · Cited by 19 · see citing works
Kim, K., Oh, H., Miller, D., Veloso, D., Lin, J., & McFarland, W. (2020) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2020.102778 · Cited by 19 · see citing works
Stam, N. C., Gerostamoulos, D., Smith, K. L., Schumann, J., & Drummer, O. H. (2018) · Clinical Toxicology · doi:10.1080/15563650.2018.1529319 · Cited by 19 · see citing works
Documenting need for naloxone distribution in the Los Angeles County jail system
Davidson, P. J., Wagner, K. D., Tokar, P. L., & Scholar, S. (2018) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.12.017 · Cited by 18 · see citing works
Håkansson, A., Alanko Blomé, M., Isendahl, P., Landgren, M., Malmqvist, U., & Troberg, K. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-074152 · Cited by 17 · see citing works
- Authors
- Bird, S. M., McAuley, A., Perry, S., & Hunter, C.
- Affiliations
- University of Strathclyde (GB)
- National Health Service Scotland (GB)
- Western Infirmary (GB)
- National Health Service (GB)
- Corresponding author
- Bird, Sheila M.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2016-02-04
- Volume
- 111
- Issue
- 5
- Pages
- 883-891
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- PMC
- PMC4982071
- OpenAlex
- W2191045458
- Cited by
- 248
- References
- 31
- Citations by year
- 2026: 14 · 2025: 17 · 2024: 20 · 2023: 18 · 2022: 13 · 2021: 42 · 2020: 24 · 2019: 23 · 2018: 29 · 2017: 30 · 2016: 14 · 2015: 1 · 2014: 1
- FWCI
- 26.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Addiction (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Strathprints: The University of Strathclyde institutional repository (University of Strathclyde) (submittedVersion, public-domain)
- ResearchOnline (Glasgow Caledonian University) (submittedVersion, other-oa)
- Funders
- Scotland's official statisticians
- National Forum on Drug Related
- National Naloxone Advisory Group (NNAG)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Keywords
- death, naloxone, opioid overdose, prisoner release, harm reduction, cost-effectiveness, life-years gained, prescription drug costs, drug policy, Scotland, prison health care, hospital discharge, pre- and post-assessment, opioid use disorder, heroin-assisted treatment, secondary care
- MeSH terms
- Adult, Aged, Analgesics, Opioid, Cost-Benefit Analysis, Female, Humans, Male, Middle Aged, Naloxone, Narcotic Antagonists, Opioid-Related Disorders, Prisoners, Scotland, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review